Amdocs Stock Analysis

Amdocs Stock Analysis Notes

About 100.0% of the company shares are held by institutions such as insurance companies. The book value of Amdocs was currently reported as 31.62. The company has Price/Earnings To Growth (PEG) ratio of 1.18. Amdocs recorded earning per share (EPS) of 5.05. The entity last dividend was issued on the 31st of December 2025. The firm had 1:4 split on the December 1, 2003. Amdocs Limited, through its subsidiaries, provides software and services worldwide. Amdocs Limited was founded in 1988 and is headquartered in Saint Louis, Missouri. Amdocs operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. To learn more about Amdocs call Joshua Sheffer at 314 212 7000 or check out https://www.amdocs.com.

Amdocs Investment Alerts

Amdocs Upcoming and Recent Events

Amdocs Largest EPS Surprises

View All Earnings Estimates

Amdocs Environmental, Social, and Governance (ESG) Scores

Amdocs Thematic Classifications

Amdocs Stock Institutional Investors

Note, although Amdocs' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Amdocs Market Capitalization

The company currently falls under 'Mid-Cap' category with a total capitalization of 8.91 B.

Amdocs Profitablity

The company has Net Profit Margin of 0.12 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.18 %, which entails that for every 100 dollars of revenue, it generated $0.18 of operating income.

Management Efficiency

Amdocs has Return on Asset of 0.0804 % which means that on every $100 spent on assets, it made $0.0804 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1629 %, implying that it generated $0.1629 on every 100 dollars invested. Amdocs' management efficiency ratios could be used to measure how well Amdocs manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.10 in 2026. Return On Capital Employed is likely to drop to 0.14 in 2026. At this time, Amdocs' Non Currrent Assets Other are fairly stable compared to the past year. Total Current Assets is likely to rise to about 1.9 B in 2026, whereas Total Assets are likely to drop slightly above 4.7 B in 2026.

Technical Drivers

As of the 6th of January, Amdocs shows the risk adjusted performance of 0.0127, and Mean Deviation of 0.8481. Amdocs technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Amdocs Price Movement Analysis

Amdocs Outstanding Bonds

Amdocs Predictive Daily Indicators

Amdocs Corporate Filings

Amdocs Forecast Models

Amdocs' time-series forecasting models are one of many Amdocs' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Amdocs' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Amdocs Bond Ratings

Amdocs financial ratings play a critical role in determining how much Amdocs have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Amdocs' borrowing costs.

Amdocs Debt to Cash Allocation

Amdocs has 826.4 M in debt with debt to equity (D/E) ratio of 0.23, which may show that the company is not taking advantage of profits from borrowing. Amdocs has a current ratio of 1.57, which is typical for the industry and considered as normal. Note however, debt could still be an excellent tool for Amdocs to invest in growth at high rates of return.

Amdocs Total Assets Over Time

Amdocs Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Amdocs uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Amdocs Debt Ratio

12.0

It appears most of the Amdocs' assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Amdocs' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Amdocs, which in turn will lower the firm's financial flexibility.

Amdocs Corporate Bonds Issued

Amdocs Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Amdocs prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Amdocs shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Amdocs. By using and applying Amdocs Stock analysis, traders can create a robust methodology for identifying Amdocs entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Amdocs analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Amdocs analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Amdocs stock analysis indicators help investors evaluate how Amdocs stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Amdocs shares will generate the highest return on investment. By understating and applying Amdocs stock analysis, traders can identify Amdocs position entry and exit signals to maximize returns.

When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.